Cancer stem cell markers for liver cancer and pancreatic cancer

Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells

“…Pancreatic CSCs contribute to tumor cell self‐renewal, differentiation, cancer recurrence, metastasis, and therapy resistance 4,5 . Markers that used to identify pancreatic CSCs include SOX2, OCT4, NANOG, ALDH1, CD24, CD44, and ESA 6,7 . Pancreatic CSCs are regulated by aberrant activation of signal pathways like NOTCH, WNT, and β‐catenin 8,9 .…”

“…4,5 Markers that used to identify pancreatic CSCs include SOX2, OCT4, NANOG, ALDH1, CD24, CD44, and ESA. 6,7 Pancreatic CSCs are regulated by aberrant activation of signal pathways like NOTCH, WNT, and βcatenin. 8,9 Therefore, targeting these signal pathways may provide new therapeutic strategies in the treatment of pancreatic cancer.…”

In situ grown magnetic COF@MOF with a phosphoserine anchor for in-depth N-glycopeptide analysis in serum

“…7 Among them, cancer antigen 125 (CA125) is a disease marker for ovarian cancer 8 and CD133 is a disease marker for liver cancer. 9 But there are still many diseases for which no disease markers have been found. Therefore, it is of medical importance to discover new disease markers to explore the pathogenesis and intervene for treatment.…”

Etching reaction of carbon quantum dot-functionalized MnO2 nanosheets with an enzymatic product for photoelectrochemical immunoassay of alpha-fetoprotein

“…Liver cancer is a malignant tumor that grows on the surface or inside of the liver, including primary and secondary liver cancers. 1 The leading cause is a viral infection with hepatitis B or C virus. Primary liver cancer originates from the epithelium or mesenchyme of the liver, and is a malignant tumor with high incidence and great harm in China.…”